Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Gamblin

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Nature Communications|December 20, 2013
Structural basis of AMPK regulation by small molecule activatorsBing Xiao, Matthew J Sanders, David Carmena, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutininYi Pu Lin, Xiaoli Xiong, Stephen A Wharton, et al.
Nature|March 15, 2011
Structure of mammalian AMPK and its regulation by ADPBing Xiao, Matthew J Sanders, Elizabeth Underwood, et al.
Cell Metabolism|October 25, 2011
ADP regulates SNF1, the Saccharomyces cerevisiae homolog of AMP-activated protein kinaseFaith V Mayer, Richard Heath, Elizabeth Underwood, et al.
Cell & Bioscience|June 17, 2024
Rapid reconstitution of ubiquitinated nucleosome using a non-denatured histone octamer ubiquitylation approachWeijie Li, Peirong Cao, Pengqi Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2015
Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibodyXiaoli Xiong, Davide Corti, Junfeng Liu, et al.
Nature Communications|April 10, 2023
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patientLena Jaki, Sebastian Weigang, Lisa Kern, et al.
Science (New York, N.Y.)|July 30, 2011
A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutininsDavide Corti, Jarrod Voss, Steven J Gamblin, et al.
Nature|November 17, 2006
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptorsShinya Yamada, Yasuo Suzuki, Takashi Suzuki, et al.
Journal of Medicinal Chemistry|October 15, 2016
Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell LymphomasRishi G Vaswani, Victor S Gehling, Les A Dakin, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Nature Communications|December 20, 2013
Structural basis of AMPK regulation by small molecule activatorsBing Xiao, Matthew J Sanders, David Carmena, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutininYi Pu Lin, Xiaoli Xiong, Stephen A Wharton, et al.
Nature|March 15, 2011
Structure of mammalian AMPK and its regulation by ADPBing Xiao, Matthew J Sanders, Elizabeth Underwood, et al.
Cell Metabolism|October 25, 2011
ADP regulates SNF1, the Saccharomyces cerevisiae homolog of AMP-activated protein kinaseFaith V Mayer, Richard Heath, Elizabeth Underwood, et al.
Cell & Bioscience|June 17, 2024
Rapid reconstitution of ubiquitinated nucleosome using a non-denatured histone octamer ubiquitylation approachWeijie Li, Peirong Cao, Pengqi Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2015
Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibodyXiaoli Xiong, Davide Corti, Junfeng Liu, et al.
Nature Communications|April 10, 2023
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patientLena Jaki, Sebastian Weigang, Lisa Kern, et al.
Science (New York, N.Y.)|July 30, 2011
A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutininsDavide Corti, Jarrod Voss, Steven J Gamblin, et al.
Nature|November 17, 2006
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptorsShinya Yamada, Yasuo Suzuki, Takashi Suzuki, et al.
Journal of Medicinal Chemistry|October 15, 2016
Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell LymphomasRishi G Vaswani, Victor S Gehling, Les A Dakin, et al.
Pageof 7